Zentalis Pharmaceuticals (ZNTL) Amortizatization of Intangibles (2020 - 2026)

Zentalis Pharmaceuticals' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $224000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 78.34% year-over-year to $224000.0; the TTM figure through Mar 2026 stood at $2.0 million (down 68.86% YoY), while the FY2025 annual figure was $2.8 million, down 65.47% from the prior year.
• Amortizatization of Intangibles was $224000.0 for Q1 2026 at Zentalis Pharmaceuticals, down from $431000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.6 million in Q4 2023 to a low of -$146000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $1.6 million across 5 years, with a median of $1.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles tumbled 150.52% in 2022, then soared 2397.67% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at $2.5 million in 2022, then soared by 83.97% to $4.6 million in 2023, then sank by 69.33% to $1.4 million in 2024, then slumped by 69.15% to $431000.0 in 2025, then slumped by 48.03% to $224000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $224000.0 (Q1 2026), $431000.0 (Q4 2025), and $517000.0 (Q3 2025), per Business Quant data.